Skip to main content

Advertisement

Log in

Bone mineral density and insulin-like growth factor-1 in children with spastic cerebral palsy

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Children with cerebral palsy (CP) have significant decrease linear growth rate and low bone mineral density (BMD).

Aims

This study is to evaluate BMD in children with CP and its relation to the levels of insulin-like growth factor-1 (IGF-1).

Subjects and methods

This cross-sectional study was carried out on 58 children suffering from spastic CP with the age range 4–12 years compared to 19 controls. All assessed by dual energy x-ray absorptiometry (DXA) to measure BMD, serum level of IGF-1, and serum vitamin D. The patients were classified according to their GMFCS.

Results

Fractures were reported in seven (12.1%) of cases. Our study demonstrated that, IGF-1 level and BMD decrease in correlation with the severity of CP. IGF-1correlates positively with serum vitamin D, BMI, and BMD. CP children with severe GMFCS level or who use anticonvulsive drugs are at a high risk for low BMD and low levels of IGF-1.

Conclusion

Both BMD and IGF-1 were significantly in low children with spastic CP; IGF-1 negatively correlates with the severity of osteopenia in children with spastic. Children with CP who are not independently ambulant or with severe GMFCS level or who use anticonvulsive drugs are at a high risk for developing low BMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Devesa J, Casteleiro N, Rodicio C, López N, Reimunde P (2010) Growth hormone deficiency and cerebral palsy. Ther Clin Risk Manag 6:413–418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Houlihan CM, Stevenson RD (2009) Bone density in cerebral palsy. Phys Med Rehabil Clin N Am 20:493–508

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ali O, Shim M, Fowler E, Cohen P, Oppenheim W (2007) Spinal bone mineral density, IGF-1 and IGFBP-3 in children with cerebral palsy. Horm Res 68:316–320

    CAS  PubMed  Google Scholar 

  4. Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29:535–559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hamza RT, Ismail MA, Hamed AI (2011) Growth hormone deficiency in children and adolescents with cerebral palsy: relation to gross motor function and degree of spasticity. Pak J Biol Sci 14:433–440

    Article  CAS  PubMed  Google Scholar 

  6. Conigilio S, Stevenson RD (1996) Apparent growth hormone deficiency in children with cerebral palsy. Dev Med Child Neurol 38:797–804

    Article  Google Scholar 

  7. Eliasson AC, Krumlinde-Sundholm L, Rösblad B, Beckung E, Arner M, Ohrvall AM, Rosenbaum P (2006) The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 48:549–554

    Article  PubMed  Google Scholar 

  8. Holick MF (2009) Vitamin D status: measurement. Interpretation and Clinical Application Ann Epidemiol 19:73–78

    Article  PubMed  Google Scholar 

  9. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE (1995) Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80:2534–2542

    CAS  PubMed  Google Scholar 

  10. Binkovitz LA, Henwood MJ (2007) Pediatric DXA: technique and interpretation. Pediatr Radiol 37:21–31

    Article  PubMed  Google Scholar 

  11. Berry SD, Samelson EJ, Pencina MJ, McLean RR, Cupples LA, Broe KE, Kiel DP (2013) Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. JAMA 310:1256–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. FeeleyB T, Gollapudi K, Otsuka NY (2007) Body mass index in ambulatory cerebral palsy patients. J Pediatr Orthop B 16:165–169

    Article  Google Scholar 

  13. Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, Conaway M, Stevenson RD (2002) Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110:e5–e5

    Article  PubMed  Google Scholar 

  14. Henderson RC, Kairalla JA, Abbas A, Stevenson RD (2004) Predicting low bone density in children and young adults with quadriplegic cerebral palsy. Dev Med Child Neurol 46:416–419

    Article  PubMed  Google Scholar 

  15. Henderson RC, Kairalla JA, Barrington JW (2005) Longitudinal changes in bone density in children and adolescents with moderate to severe cerebral palsy. J Pediatr 146:769–775

    Article  PubMed  Google Scholar 

  16. Gilbert SR, Gilbert AC, Henderson RC (2004) Skeletal maturation in children with quadriplegic cerebral palsy. J Pediatr Orthop 24(3):292–297

    Article  PubMed  Google Scholar 

  17. Stevenson RD, Conaway M, Barrington JW, Cuthill SL, Worley G, Henderson RC (2006) Fracture rate in children with cerebral palsy. Pediatr Rehabil 9:396–403

    Article  PubMed  Google Scholar 

  18. Jekovec-Vrhovsek M, Kocijancic A, Prezelj J (2000) Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev Med Child Neurol 42:403–405

    Article  CAS  PubMed  Google Scholar 

  19. Mohan S, Baylink DJ (2005) Impaired skeletal growth in mice with haploinsufficiency of IGF-1: genetic evidence that differences in IGF-1 expression could contribute to peak bone mineral density differences. J Endocrinol 185:415–420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Houlihan CM (2014) Bone health in cerebral palsy: who’s at risk and what to do about it? J Pediatr Rehabil Med 7:143–153

    PubMed  Google Scholar 

  21. Tasdemir HA, Buyukavci M, Akcay F, Polat P, Yildiran AKarakelleoglu C (2001) Bone mineral density in children with cerebral palsy. Pediatr Int 43:157–160

    Article  CAS  PubMed  Google Scholar 

  22. King W, Levin R, Schmidt R, Oestreich A, Heubi JE (2003) Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol 45:12–16

    Article  PubMed  Google Scholar 

  23. Hartman C, Brik R, Tamir A, Merrick J, Shamir R (2004) Bone quantitative ultrasound and nutritional status in severely handicapped institutionalized children and adolescents. Clin Nutr 23:89–98

    Article  CAS  PubMed  Google Scholar 

  24. Chad KE, McKay HA, Zello GA, Bailey DA, Faulkner RA, Snyder RE (2000) Body composition in nutritionally adequate ambulatory and non-ambulatory children with cerebral palsy and a healthy reference group. Dev Med Child Neurol 42:334–339

    Article  CAS  PubMed  Google Scholar 

  25. Ali O, Shim M, Fowler E, Greenberg M, Perkins D, Oppenheim W, Cohen P (2007) Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study. J Clin Endocrinol Metab 92:932–937

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Elsayed.

Ethics declarations

Parents were informed about the aims and the procedures of the study. A written informed consent was signed from parents to enroll their children in the study as well as an ascent from the patient. The study was approved by the local ethical committee of our hospital.

Conflict of interest

All authors stated that no conflict of interest related to this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nazif, H., Shatla, R., Elsayed, R. et al. Bone mineral density and insulin-like growth factor-1 in children with spastic cerebral palsy. Childs Nerv Syst 33, 625–630 (2017). https://doi.org/10.1007/s00381-017-3346-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-017-3346-9

Keywords

Navigation